4.5 Article

Novel compounds produced by Streptomyces lydicus NRRL 2433 engineered mutants altered in the biosynthesis of streptolydigin

Journal

JOURNAL OF ANTIBIOTICS
Volume 65, Issue 7, Pages 341-348

Publisher

JAPAN ANTIBIOTICS RESEARCH ASSOC
DOI: 10.1038/ja.2012.37

Keywords

cytochrome P450; nonribosomal peptide; polyketide; silenced pathway; streptolydigin; Streptomyces; tetramic acid

Funding

  1. Spanish Ministry of Science and Innovation [BFU2006-00404, SAF2008-01845]
  2. Red Tematica de Investigacion Cooperativa de Centros de Cancer (Ministry of Health) [ISCIII-RETIC RD06/0020/0026]
  3. Obra Social Cajastur
  4. Centro de Investigacion Principe Felipe

Ask authors/readers for more resources

Streptolydigin is a tetramic acid antibiotic produced by Streptomyces lydicus NRRL 2433 and involving a hybrid polyketide synthase (PKS)-nonribosomal peptide synthetase (NRPS) system in its biosynthesis. The streptolydigin amino-acid precursor, 3-methylaspartate, has been proposed to be condensed to the polyketide portion of the molecule by a NRPS composed by three enzymes (SlgN1, SlgN2 and SlgL). On the other hand, biosynthesis of the polyketide moiety involves the participation of cytochrome P450 SlgO2 for the correct cyclization of the characteristic bicyclic ketal. Independent disruption of slgN1, slgN2, slgL or slgO2 resulted in S. lydicus mutants unable to produce the antibiotic thus confirming the involvement of these genes in the biosynthesis of the antibiotic. These mutants did not accumulate any streptolydigin biosynthesis intermediate or shunt product derived from early polyketides released from the PKS. However, they produced three novel compounds identified as 4-(2-carboxy-propylamino)-3-chloro-benzoic acid, 4-(2-carboxy-propylamino)-3-hydroxy-benzoic acid and 4-(2-carboxy-propylamino)-benzoic acid, which were designated as christolane A, christolane B and christolane C, respectively. These compounds have been shown to exert some antibiotic activity. The Journal of Antibiotics (2012) 65, 341-348; doi: 10.1038/ja.2012.37; published online 9 May 2012

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort

R. Conde, R. Laires, L. G. Goncalves, A. Rizvi, C. Barroso, M. Villar, R. Macedo, M. J. Simoes, S. Gaddam, P. Lamosa, L. Puchades-Carrasco, A. Pineda-Lucena, A. B. Patel, S. C. Mande, S. Banerjee, M. Matzapetakis, A. Coelho

Summary: This study utilized Nuclear Magnetic Resonance based metabolomics to discover a signature of biomarkers for tuberculosis diagnosis. Six metabolites associated with TB infection were validated, in line with the recommendations of the World Health Organization.

BIOMEDICAL JOURNAL (2022)

Article Oncology

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Borja Ruiz-Fernandez de Cordoba, Haritz Moreno, Karmele Valencia, Naiara Perurena, Pablo Ruedas, Thomas Walle, Alberto Pezonaga-Torres, Juan Hinojosa, Elisabet Guruceaga, Antonio Pineda-Lucena, Marta Abengozar-Muela, Denis Cochonneau, Carolina Zandueta, Susana Martinez-Canarias, Alvaro Teijeira, Daniel Ajona, Sergio Ortiz-Espinosa, Xabier Morales, Carlos Ortiz de Solorzano, Marta Santisteban, Luis Ramos-Garcia, Laura Guembe, Vratislav Strnad, Dominique Heymann, Sandra Hervas-Stubbs, Ruben Pio, Maria E. Rodriguez-Ruiz, Carlos E. de Andrea, Silvestre Vicent, Ignacio Melero, Fernando Lecanda, Rafael Martinez-Monge

Summary: Locoregional failure in breast cancer patients after surgery and irradiation is linked to a poor prognosis. The ENPP1/HP axis is exploited by tumor cells to promote local recurrence by suppressing immune cells. Blocking this axis offers new opportunities for therapeutic intervention.

CANCER DISCOVERY (2022)

Review Oncology

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches

Nuria Gomez-Cebrian, Jose Luis Poveda, Antonio Pineda-Lucena, Leonor Puchades-Carrasco

Summary: Prostate cancer is a heterogeneous tumor with a highly variable clinical outcome. Integrating multi-omics datasets can be a powerful approach for developing novel metabolic signatures to improve the clinical management of prostate cancer patients.

CANCERS (2022)

Article Cell Biology

Metabolic Alterations in a Drosophila Model of Parkinson's Disease Based on DJ-1 Deficiency

Cristina Solana-Manrique, Francisco Jose Sanz, Isabel Torregrosa, Martina Palomino-Schatzlein, Carolina Hernandez-Oliver, Antonio Pineda-Lucena, Nuria Paricio

Summary: The study investigates metabolic disturbances underlying the pathogenesis of Parkinson's disease (PD) using a Drosophila PD model. Through metabolomic analysis, the study finds that metabolic alterations are associated with PD and could potentially serve as therapeutic targets and biomarkers for the disease.

CELLS (2022)

Article Biochemistry & Molecular Biology

Folding of the nascent polypeptide chain of a histidine phosphocarrier protein in vitro

Jose L. Neira, Martina Palomino-Schatzlein

Summary: The phosphotransferase system (PTS), consisting of five proteins, regulates the use of sugars in bacteria. The second protein in the chain, HPr, plays a role in bacterial carbon sources utilization and can be phosphorylated at Ser46. Additionally, two other proteins, Rsd and HPrIVP, bind to HPr at His15. Fragments of HPr were designed and shown to be mainly disordered but still capable of binding to their respective protein partners. Binding was related to the presence of a weak native-like structure around His15.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2023)

Article Environmental Sciences

Multibiomarker approach in fish to assess a heavily polluted Brazilian estuary, Guanabara Bay

Marina Moreira Freire, Cristina Gomez, Josino Costa Moreira, Ana Rosa Linde Arias

Summary: This study evaluates the impact of contamination in Brazil's Guanabara Bay on two fish species using a multibiomarker approach. The results indicate that fish in the bay are greatly affected by environmental pollution, specifically heavy metal and polycyclic aromatic hydrocarbon exposure.

ENVIRONMENTAL MONITORING AND ASSESSMENT (2023)

Article Biotechnology & Applied Microbiology

Biohydrogen Production in Microbial Electrolysis Cell Operating on Designed Consortium of Denitrifying Bacteria

Putty Ekadewi, Rita Arbianti, Cristina Gomez, Tania Surya Utami

Summary: This study explores the use of a designed microbial community to produce biohydrogen in single-chamber microbial electrolysis cells (MECs). By using a designed consortium, the competition of metabolic pathways can be avoided. The MECs inoculated with the designed consortium showed better hydrogen production performance compared to those inoculated with a natural soil consortium.

FOOD TECHNOLOGY AND BIOTECHNOLOGY (2023)

Article Medicine, General & Internal

The Footprint of Type 1 Diabetes on Red Blood Cells: A Metabolomic and Lipidomic Study

Jose Raul Herance, Andreea Ciudin, Ruben Lamas-Domingo, Carolina Aparicio-Gomez, Cristina Hernandez, Rafael Simo, Martina Palomino-Schatzlein

Summary: The prevalence of diabetes type 1 (T1D) is increasing worldwide. This study aimed to find new biomarkers of T1D in red blood cells (RBCs), which have not been explored before. The metabolomic and lipidomic profiles of RBCs from T1D patients and healthy controls were analyzed using NMR spectroscopy. Significant changes were observed in amino acids, organic acids, creatine, phosphocreatine, lipid length, and choline derivatives. These changes indicate alterations in glycolysis, BCAA metabolism, and phospholipid metabolism. The study concluded that the metabolic and lipidomic profile of RBCs can be used as biomarker candidates for the earlier diagnosis and monitoring of T1D patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Uncovering the Cryptic Gene Cluster ahb for 3-amino-4-hydroxybenzoate Derived Ahbamycins, by Searching SARP Regulator Encoding Genes in the Streptomyces argillaceus Genome

Suhui Ye, Brian Molloy, Ignacio Perez-Victoria, Ignacio Montero, Alfredo F. Brana, Carlos Olano, Sonia Arca, Jesus Martin, Fernando Reyes, Jose A. Salas, Carmen Mendez

Summary: Genome mining using bioinformatics tools allowed for uncovering hidden biosynthesis gene clusters, while an alternative approach involving the analysis of Streptomyces Antibiotic Regulatory Proteins (SARP) encoding genes was used to identify cryptic gene clusters. This strategy led to the discovery of the new ahb cluster in Streptomyces argillaceus and the identification of ahbamycins as a new family of metabolites with antibiotic and antitumor activity. Further investigation revealed a hybrid compound, AHB18, produced through metabolic crosstalk between the ahb and argimycin P pathways. This finding opens up possibilities for generating new compounds through combinatorial biosynthesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Food Science & Technology

MicotoXilico: An Interactive Database to Predict Mutagenicity, Genotoxicity, and Carcinogenicity of Mycotoxins

Josefa Tolosa, Eva Serrano Candelas, Jose Luis Valles Pardo, Addel Goya, Salvador Moncho, Rafael Gozalbes, Martina Palomino Schaetzlein

Summary: Mycotoxins, which are produced by fungi, pose a threat to public health due to their potential carcinogenic, mutagenic, and teratogenic effects. This study developed a comprehensive database of 4360 mycotoxins classified into 170 categories. The use of QSAR models allowed for accurate and reliable prediction of mutagenicity, genotoxicity, and carcinogenicity, meeting regulatory criteria. The integrated web server provides a valuable tool for exploring the mycotoxin database and predicting toxicity.

TOXINS (2023)

Article Microbiology

Co-Expression of Transcriptional Regulators and Housekeeping Genes in Streptomyces spp.: A Strategy to Optimize Metabolite Production

Lorena Cuervo, Monica G. Malmierca, Raul Garcia-Salcedo, Carmen Mendez, Jose A. Salas, Carlos Olano, Ana Ceniceros

Summary: The search for novel bioactive compounds to overcome resistance to current therapeutics has become crucial. Streptomyces spp. are a major source of bioactive compounds used in medicine. In this study, global transcriptional regulators and housekeeping genes known to enhance secondary metabolite production in Streptomyces coelicolor were cloned and expressed in different strains. The recombinant plasmids were also inserted into Streptomyces strains with enhanced secondary metabolism. Media with varied carbon and nitrogen sources were used, and the strains' metabolite production was analyzed. The study demonstrated the overproduction and activation of known metabolites and the potential for manipulating Streptomyces metabolism and exploring their wide range of secondary metabolites.

MICROORGANISMS (2023)

Article Biochemistry & Molecular Biology

Identification of the Biosynthetic Gene Cluster of New Piperazic Acid-Containing Lipopeptides with Cytotoxic Activity in the Genome of Marine Streptomyces PHM034

Ana Ceniceros, Librada Canedo, Carmen Mendez, Carlos Olano, Carmen Schleissner, Carmen Cuevas, Fernando de la Calle, Jose A. Salas

Summary: Three novel lipopeptides were isolated from a marine sediment-derived Streptomyces tuirus and they exhibited cytotoxic activity against human cancer cell lines. The biosynthesis of these lipopeptides was found to be dependent on a gene cluster.

METABOLITES (2023)

Article Microbiology

Streptomyces albidoflavus Q antifungal metabolites inhibit the ergosterol biosynthesis pathway and yeast growth in fluconazole-resistant Candida glabrata: phylogenomic and metabolomic analyses

Celia Bautista-Crescencio, Arturo Casimiro-Ramos, M. Jonathan Fragoso-Vazquez, Jose Correa-Basurto, Carlos Olano, Cesar Hernandez-Rodriguez, Lourdes Villa-Tanaca

Summary: There is an urgent need to develop new antifungals due to the increasing prevalence of multidrug-resistant fungal infections and the recent emergence of COVID-19-associated candidiasis. In this study, antifungal metabolites produced by Streptomyces albidoflavus Q were investigated, and two secondary metabolites were found to have a good inhibitory effect on Candida glabrata, which may be potential candidates for treating fungal infections.

MICROBIOLOGY SPECTRUM (2023)

No Data Available